EFSA comment rebuttal shows product-specific claims are not the way to go, says expert
EFSAs rebuttal of claims that a recent positive scientific opinion should have related to a whole product rather than a single constituent reaffirm the belief that product-specific health claims are not viable, according to one consultant.